Evidence map›Paper›PMID 29869069›Full record

ArticleJournal of physiology and biochemistry2018

PTRF acts as an adipokine contributing to adipocyte dysfunctionality and ectopic lipid deposition.

Sergio Perez-Diaz, Maria P Garcia-Sobreviela, Yolanda Gonzalez-Irazabal, Beatriz Garcia-Rodriguez, Silvia Espina, Izaskun Arenaz, Jose M Arbones-Mainar

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. The crosstalk: exosomes and lipid metabolism.Cell communication and signaling : CCS · 2020
    Review
  8. Lessons from cavin-1 deficiency.Biochemical Society transactions · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sergio Perez-DiazAdipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Instituto Aragonés de Ciencias de la Salud (IACS), Instituto de Investigación Sanitaria (IIS) Aragón, Hospital Universitario Miguel Servet, Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Maria P Garcia-SobrevielaAdipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Instituto Aragonés de Ciencias de la Salud (IACS), Instituto de Investigación Sanitaria (IIS) Aragón, Hospital Universitario Miguel Servet, Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Yolanda Gonzalez-IrazabalServicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Beatriz Garcia-RodriguezServicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Silvia EspinaAdipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Instituto Aragonés de Ciencias de la Salud (IACS), Instituto de Investigación Sanitaria (IIS) Aragón, Hospital Universitario Miguel Servet, Isabel la Católica, 1-3, 50009, Zaragoza, Spain.
Izaskun ArenazBiobanco del Sistema de Salud de Aragón, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain.
Jose M Arbones-MainarAdipocyte and Fat Biology Laboratory (AdipoFat), Unidad de Investigación Traslacional, Instituto Aragonés de Ciencias de la Salud (IACS), Instituto de Investigación Sanitaria (IIS) Aragón, Hospital Universitario Miguel Servet, Isabel la Católica, 1-3, 50009, Zaragoza, Spain. jmarbones.iacs@aragon.es.ORCID http://orcid.org/0000-0002-8982-3737
Hospital Universitario Miguel Servet · ESInstituto Aragonés de Ciencias de la Salud · ESInstituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos III (ES) PI14/00508
6 · The paper itself

Abstract

Adipose tissue (AT) expands under obesogenic conditions. Yet, when the growth exceeds a certain limit, AT becomes dysfunctional and surplus lipids start depositing ectopically. Polymerase I and transcription release factor (PTRF) has been proposed as a mechanism leading to a dysfunctional AT by decreasing the adipogenic potential of human adipocyte precursors. However, whether or not PTRF can be secreted by the adipocytes into the bloodstream is not yet known. For this work, PTRF presence was investigated in plasma. We also produced a recombinant PTRF (rPTRF) and examined its impact on the functional interactions between the adipocyte and the hepatocyte in vitro. We demonstrated that PTRF can be found in human plasma, and is at least in part, carried by exosomes. In vitro treatment with rPTRF increased the hypertrophy and senescence of 3T3-L1 adipocytes. In turn, those rPTRF-treated adipocytes increased lipid accumulation in hepatocytes. Lastly, we found a positive correlation between circulating PTRF and the concentration of PTRF in the visceral fat depot. All these findings point toward the presence of an enlarged and dysfunctional visceral adipose tissue which secretes PTRF. This circulating PTRF behaves as an adipokine and may partially contribute to the well-known detrimental effects of visceral fat accumulation.

Indexed as

Lipid Metabolism3T3-L1 CellsAbsorption, PhysiologicalAnimalsCell SizeCellular SenescenceCohort StudiesCulture Media, ConditionedExosomesFemaleGlucoseHepatocytesHep G2 CellsHumansIntra-Abdominal FatMaleCAVIN1 protein, humanCavin1 protein, mouseCulture Media, ConditionedGlucoseMembrane ProteinsRecombinant ProteinsRNA-Binding ProteinsAdiposeCavin-1SenescenceVisceral fat

Identifiers

PMID29869069
OpenAlexW2807050169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.